Developmental risk factors for unintentional childhood poisoning

Related Experiment Video

Updated: Oct 8, 2026

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

H Soori1

  • 1Department of Community Medicine, The Medical School, University of Ahwaz Medical Sciences, Ahwaz, Iran.

Saudi Medical Journal
|April 18, 2001
PubMed

Insights

Unsupervised children and those with prior poisoning incidents face a higher risk of unintentional poisoning. Safe storage of hazardous products and increased parental supervision are crucial for prevention.

Area of Science:

  • Pediatrics
  • Toxicology
  • Public Health

Background:

  • Unintentional childhood poisoning remains a significant public health concern globally.
  • Identifying specific risk factors is essential for developing targeted prevention strategies.

Purpose of the Study:

  • To determine the primary risk factors associated with unintentional childhood poisoning in Ahwaz, Iran.
  • To propose potential causes and effective preventative measures for childhood poisoning.

Main Methods:

  • An epidemiological case-control study was conducted in Ahwaz, Iran, from 1996 to 1997.
  • 100 children treated for poisoning (cases) were compared with 200 matched controls.
  • Parental interviews using a questionnaire gathered demographic and poisoning characteristic data.

Main Results:

  • Lack of adult supervision (OR=4.8) and a history of previous poisoning (OR=5.2) significantly increased poisoning risk.
  • Drug poisoning was most common (60%), predominantly occurring within the home (89%).
  • Children aged 2-4 years (79%) and boys were disproportionately affected; hazardous products were accessible in 75% of cases.

Conclusions:

  • Enhanced parental supervision and secure handling, storage, and disposal of hazardous substances are paramount for preventing childhood poisoning.
  • Mandating child-resistant containers and clear warning labels on toxic household products and medications is recommended for manufacturers and retailers.
Abstract

More Related Videos

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...